InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（0 笔）
内部人交易记录
高级管理人员已披露买入
0
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Discover the detailed record of transactions filed by Hansen Brian B, Vice-Président Exécutif. Director active across 4 companies, notably TANDEM DIABETES CARE INC. Cumulatively, 22 filings have been recorded. Activity tracked since 17 May 2021. The latest transaction was disclosed on 19 May 2026 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Hansen Brian B
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报22 总计
90,253 股0Common StockSEC:0001542377-26-000002:0
842,084 股0Common StockSEC:0001415889-25-014860:0
406 股0Common StockSEC:0001438133-23-000245:0
1 股@ US$15.470.0% 占其流量Common StockSEC:0001438133-23-000230:0
407 股0Common StockSEC:0001438133-23-000189:0
162 股0Common StockSEC:0001438133-23-000172:0
406 股0Common StockSEC:0001438133-23-000130:0
631 股@ US$27.3224.4% 占其流量Common StockSEC:0001438133-23-000084:0
407 股0Common StockSEC:0001438133-23-000040:0
162 股0Common StockSEC:0001438133-23-000014:0
406 股0Common StockSEC:0001438133-22-000245:0
163 股0Common StockSEC:0001438133-22-000229:0
407 股0Common StockSEC:0001438133-22-000203:0
162 股0Common StockSEC:0001438133-22-000189:0
406 股0Common StockSEC:0001438133-22-000147:0
650 股0Common StockSEC:0001438133-22-000075:0
407 股0Common StockSEC:0001438133-22-000031:0
406 股0Common StockSEC:0001438133-21-000214:0
2,180 股@ US$9.0034.1% 占其流量Common StockSEC:0001438133-21-000165:0
407 股0Common StockSEC:0001438133-21-000153:0
1,626 股0Common StockSEC:0001438133-21-000077:0
296 股@ US$66.7633.4% 占其流量Common StockSEC:0001438133-21-000059:0
22 条申报中的 22 条
About Hansen Brian B
HANSEN BRIAN B is Executive Vice President. He has 22 filings in total. In the recent filings available, the most common transaction nature is option exercise, and the covered period runs from 2021-05-20 to 2026-05-21. The buy and sell amounts shown for this recent sample are 0 and 0 EUR, with filings notably at Tandem Diabetes Care INC and Senseonics Holdings, Inc.
